Northern Trust Corp Innoviva, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Innoviva, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 652,615 shares of INVA stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
652,615
Previous 651,579 0.16%
Holding current value
$11.6 Million
Previous $10.7 Million 17.88%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$16.33 - $20.04 $16,917 - $20,761
1,036 Added 0.16%
652,615 $12.6 Million
Q2 2024

Aug 14, 2024
SELL
$14.4 - $16.4 $413,496 - $470,925
-28,715 Reduced 4.22%
651,579 $10.7 Million
Q1 2024

May 14, 2024
SELL
$14.56 - $16.78 $595,198 - $685,949
-40,879 Reduced 5.67%
680,294 $10.4 Million
Q4 2023

Feb 13, 2024
SELL
$12.32 - $16.27 $31,477 - $41,569
-2,555 Reduced 0.35%
721,173 $11.6 Million
Q3 2023

Nov 13, 2023
SELL
$12.37 - $13.89 $195,841 - $219,906
-15,832 Reduced 2.14%
723,728 $9.4 Million
Q2 2023

Aug 11, 2023
SELL
$11.39 - $13.72 $224,667 - $270,627
-19,725 Reduced 2.6%
739,560 $9.41 Million
Q1 2023

May 15, 2023
SELL
$10.73 - $13.6 $49,400 - $62,614
-4,604 Reduced 0.6%
759,285 $8.54 Million
Q4 2022

Feb 13, 2023
BUY
$11.8 - $13.78 $439,184 - $512,877
37,219 Added 5.12%
763,889 $10.1 Million
Q3 2022

Nov 14, 2022
SELL
$11.61 - $15.22 $26,110 - $34,229
-2,249 Reduced 0.31%
726,670 $8.44 Million
Q2 2022

Aug 12, 2022
BUY
$14.32 - $19.88 $1.92 Million - $2.66 Million
133,748 Added 22.47%
728,919 $10.8 Million
Q1 2022

May 13, 2022
SELL
$15.39 - $20.25 $321,127 - $422,536
-20,866 Reduced 3.39%
595,171 $11.5 Million
Q4 2021

Feb 08, 2022
SELL
$15.91 - $18.72 $296,546 - $348,922
-18,639 Reduced 2.94%
616,037 $10.6 Million
Q3 2021

Nov 15, 2021
SELL
$13.06 - $17.24 $1.94 Million - $2.57 Million
-148,879 Reduced 19.0%
634,676 $10.6 Million
Q2 2021

Aug 13, 2021
SELL
$11.45 - $13.96 $292,307 - $356,384
-25,529 Reduced 3.16%
783,555 $10.5 Million
Q1 2021

May 12, 2021
SELL
$11.06 - $12.87 $626,737 - $729,304
-56,667 Reduced 6.55%
809,084 $9.67 Million
Q4 2020

Feb 11, 2021
SELL
$9.33 - $12.48 $331,942 - $444,013
-35,578 Reduced 3.95%
865,751 $10.7 Million
Q3 2020

Nov 16, 2020
SELL
$10.33 - $14.49 $735,268 - $1.03 Million
-71,178 Reduced 7.32%
901,329 $9.42 Million
Q2 2020

Aug 14, 2020
BUY
$11.49 - $15.26 $856,786 - $1.14 Million
74,568 Added 8.3%
972,507 $13.6 Million
Q1 2020

May 14, 2020
BUY
$8.11 - $15.23 $83,103 - $156,061
10,247 Added 1.15%
897,939 $10.6 Million
Q4 2019

Feb 14, 2020
SELL
$10.28 - $14.38 $249,886 - $349,549
-24,308 Reduced 2.67%
887,692 $12.6 Million
Q3 2019

Nov 13, 2019
SELL
$10.05 - $14.55 $368,483 - $533,475
-36,665 Reduced 3.86%
912,000 $9.61 Million
Q2 2019

Aug 13, 2019
BUY
$13.1 - $14.95 $148,016 - $168,920
11,299 Added 1.21%
948,665 $13.8 Million
Q1 2019

May 13, 2019
BUY
$13.69 - $20.06 $55,595 - $81,463
4,061 Added 0.44%
937,366 $13.2 Million
Q4 2018

Feb 12, 2019
SELL
$13.96 - $18.26 $146,203 - $191,236
-10,473 Reduced 1.11%
933,305 $16.3 Million
Q3 2018

Nov 14, 2018
SELL
$13.63 - $15.7 $780,849 - $899,437
-57,289 Reduced 5.72%
943,778 $14.4 Million
Q2 2018

Sep 18, 2018
SELL
$13.44 - $17.59 $91,365 - $119,576
-6,798 Reduced 0.67%
1,001,067 $13.8 Million
Q2 2018

Aug 14, 2018
SELL
$13.44 - $17.59 $339,655 - $444,534
-25,272 Reduced 2.45%
1,007,865 $13.9 Million
Q1 2018

May 09, 2018
SELL
$13.8 - $16.99 $174,266 - $214,549
-12,628 Reduced 1.21%
1,033,137 $17.2 Million
Q4 2017

Feb 14, 2018
SELL
$11.73 - $14.75 $2.17 Million - $2.73 Million
-185,045 Reduced 15.03%
1,045,765 $14.8 Million
Q3 2017

Nov 13, 2017
BUY
$12.06 - $14.12 $14.8 Million - $17.4 Million
1,230,810
1,230,810 $17.4 Million

Others Institutions Holding INVA

# of Institutions
227
Shares Held
78.9M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email